The FDA has granted marketing authorization to CT-132 for the preventive treatment of episodic migraine in patients aged 18 years and older.

FDA Cleared Nerivio® REN Wearable Offers Non-Drug Treatment Option for Millions of People With Migraine as Young as 8. NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- For millions o ...

For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged. These medications are proving to be highly effective for migraine ...

Helper. It uses dry air to cool the nasal passage and helps stop the activation of the part of the brain that is turned on ...

Research hasn’t confirmed if daith ear piercings help migraines. Some people claim this piercing benefits their migraines.

Children and adolescents treated with fremanezumab experienced fewer migraine and headache days compared with placebo, according to an abstract presented at the American Academy of Neurology Annual ...

But drug-free treatment options are making it easier to manage migraine – without the debilitating side effects. Recently. Neurologist and Migraine Specialist, Dr. Aliya Frederick, along with ...

(MENAFN- GlobeNewsWire - Nasdaq) FDA Cleared Nerivio® REN Wearable Offers Non-Drug Treatment Option for Millions of People With Migraine as Young as 8 NEW YORK, April 21, 2025 (GLOBE NEWSWIRE ...

Fremanezumab is a calcitonin-gene related peptide (CGRP) pathway monoclonal antibody that is FDA approved for adults with ...

CT-132 statistically significantly reduced monthly migraine days compared with sham digital treatment after 12 weeks. The Food and Drug Administration (FDA) has granted marketing authorization to ...